Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05966038 · ClinicalTrials.gov registry record
ALS/MND Natural History Study Data Repository
A clinical trial of ALS and PLS, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 16
- Study locations
NCT05966038: Recruiting study of ALS and PLS, sponsored by Massachusetts General Hospital.
NCT05966038 is a study of ALS and PLS that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 5,000 participants, above the 774-participant average among 19 other ALS trials with a reported enrollment target (546% higher). The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05966038, a study of ALS and PLS, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND). All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study. The Sites collect so-called Baseline information including demographics, disease history and diagnosis, family history, etc. At each visit, the Sites also collect multiple disease-specific outcome measures and events. The information is captured in NeuroBANK, a patient-centric clinical research platform. The Sites have an option to choose to collect data into 20+ additional forms capturing biomarkers and outcome measures. Captured data after its curation are anonymized (all personal identifiers and dates are being removed), and the anonymized dataset is shared with medical researchers via a non-exclusive revocable license. Funding Source - Biogen, Inc.; Mitsubishi Tanabe Pharma America; FDA OOPD.
Primary Outcome
The ALS Functional Rating Scale revised is a 12-item rating scale that measures the progression of disability in patients with ALS. The ALSFRS-r assesses patients' levels of self-sufficiency in areas of feeding, grooming, ambulation and communication. The higher the score, the earlier in the disease progression. It consists of 12 questions with a maximum score of 48 points.
Conditions Studied
Study Locations (16)
Other
- Hadassah Medical Organization - Jerusalem
- Tel Aviv Medical Center - Tel Aviv
- Centro Clinico NEMO Milano - Milan
- Istituti Clinici Scientifici Maugeri SpA - Milan
California
- Loma Linda University Health - Loma Linda
- Kaiser Permanente - Los Angeles
Pennsylvania
- Temple University Lewis Katz School of Medicine - Philadelphia
- University of Pittsburgh - Pittsburgh
Florida
- University of Florida - Gainesville
Illinois
- Northwestern University - Chicago
Massachusetts
- Lahey Clinic - Burlington
Michigan
- Henry Ford Health System - Detroit
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-04-01 |
| Est. Completion | 2030-12-31 |
What NCT05966038 shows while recruiting
NCT05966038 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 774-participant average among 19 other ALS trials with a reported enrollment target (546% higher).
The record links to 6 conditions, with ALS appearing as the primary indexed condition, and to 0 interventions.
NCT05966038 lists 16 locations in 11 states (Other, California, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT05966038 about?
NCT05966038 is a clinical study titled "ALS/MND Natural History Study Data Repository". This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND). All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study. The Sites collect so-called ...
What is the current status of trial NCT05966038?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-04-01. Estimated completion is 2030-12-31.
What conditions does trial NCT05966038 study?
This clinical trial studies the following conditions: ALS, PLS, MND (Motor Neurone DIsease), Kennedy Disease, PMA - Progressive Muscular Atrophy.
Who is sponsoring clinical trial NCT05966038?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05966038 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ALS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05966038's enrollment target sits among peer trials
5,000 2nd of 19 the highest of 19 other ALS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ALS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RECRUITING · Phase 1
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
RECRUITING · NA
-
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
RECRUITING · NA
-
ECoG BMI for Motor and Speech Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI